Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Andrew S. Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick D.E. Zeeuw; Thomas H. Hostetter; Norbert Lameire; Garabed Eknoyan

doi:10.1111/j.1523-1755.2005.00365.x

journal article Open Access Jun 01, 2005

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Andrew S. Levey

Kai-Uwe Eckardt

Yusuke Tsukamoto Adeera Levin

Josef Coresh

Jerome Rossert Dick D.E. Zeeuw Thomas H. Hostetter Norbert Lameire Garabed Eknoyan

Kidney International Vol. 67 No. 6 pp. 2089-2100 · Elsevier BV

View at Publisher Save 10.1111/j.1523-1755.2005.00365.x

Topics

No keywords indexed for this article. Browse by subject →

References

27

[1]

Eknoyan "The burden of kidney disease: Improving global outcomes" Kidney Int (2004) 10.1111/j.1523-1755.2004.00894.x

[2]

Steinberg "Improving the quality of care—Can we practice what we preach?" N Engl J Med (2003) 10.1056/nejme030085

[3]

(1999)

[4]

Horton (2003)

[5]

National Kidney Foundation "K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification" Am J Kidney Dis (2002)

[6]

Kausz "The care of patients with chronic kidney disease: What must we do and who should do it?" J Gen Intern Med (2002) 10.1046/j.1525-1497.2002.20634.x

[7]

Eknoyan "Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes Digestive and Kidney Diseases (NIDDK)" Am J Kidney Dis (2003) 10.1016/s0272-6386(03)00826-6

[8]

Levey "National Kidney Foundation Disease Outcomes Quality Initiative Clinic Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification" Am J Kidney Dis (2003)

[9]

Uhlig "New guidelines spell out approach to chronic kidney disease" (2003)

[10]

Johnson "Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment and risk factors" (2004)

[11]

Johnson "Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers" (2004)

[12]

BAILIE GR, UHLIG K, LEVEY AS: Clinical practice guidelines innephrology: Evaluation, classification and stratification. Pharmacotherapy(in press)

[13]

Colandonato "Perception vs. reality of the burden of chronic kidney disease in the US" J AmSoc Nephrol (2002)

[14]

Chen "Controversies in nephrology: Should the K/DOQI definition of chronic kidney disease be changed?" Am J Kidney Dis (2003) 10.1016/s0272-6386(03)00870-9

[15]

Levey "Controversies in nephrology: Should the K/DOQI definition of chronic kidney disease be changed?" Am J Kidney Dis (2003) 10.1016/s0272-6386(03)00827-8

[16]

Clase "Classifying kidney problems: Can we avoid framing risks as diseases?" BMJ (2004) 10.1136/bmj.329.7471.912

[17]

Lin "A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease" J Am Soc Nephrol (2003) 10.1097/01.asn.0000088721.98173.4b

[18]

Bostom "Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels" J Am Soc Nephrol (2002) 10.1097/01.asn.0000022011.35035.f3

[19]

Rule "Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease" Ann Intern Med (2004) 10.7326/0003-4819-141-12-200412210-00009

[20]

Stevens "Clinical implications of estimating equations for glomerular filtration rate" Ann Intern Med (2004) 10.7326/0003-4819-141-12-200412210-00013

[21]

Levey "Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?" Am J Kidney Dis (1998) 10.1016/s0272-6386(98)70145-3

[22]

Sarnak "Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention" Circulation (2003) 10.1161/01.cir.0000095676.90936.80

[23]

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

Aram V. Chobanian

JAMA 2003 10.1001/jama.289.19.2560

[24]

National Kidney Foundation "K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease" Am J Kidney Dis (2004)

[25]

Mattix J Am Soc Nephrol (2002) 10.1681/asn.v1341034

[26]

Jacobs Am J Epidemiol (2002) 10.1093/aje/155.12.1114

[27]

Warram "Effect of duration of type 1 diabetes o the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio" J Am Soc Nephrol (1996) 10.1681/asn.v76930

Cited By

2,927

Predictive factors for percutaneous nephrolithotomy bleeding risks

U Phun Loo, Chun Hou Yong · 2024

Asian Journal of Urology

Joint association of loneliness and traditional risk factor control and incident cardiovascular disease in diabetes patients

Xuan Wang, Hao Ma · 2023

European Heart Journal

Circulating Extracellular Vesicle-Propagated microRNA Signature as a Vascular Calcification Factor in Chronic Kidney Disease

Takaaki Koide, Shintaro Mandai · 2023

Circulation Research

Impact of Early versus Late Referral to Nephrologists on Outcomes of Chronic Kidney Disease Patients in Northern India

Manoj Dhanorkar, Narayan Prasad · 2022

International Journal of Nephrology

Osteoporosis and Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Back to Basics

Michael Pazianas · 2021

American Journal of Kidney Diseases

Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score study

Yolanda Meije, Carles Pigrau · 2019

International Journal of Antimicrob...

Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup

Lakhmir S. Chawla, Rinaldo Bellomo · 2017

Nature Reviews Nephrology

Current Issues in Measurement and Reporting of Urinary Albumin Excretion

W Greg Miller, David E Bruns · 2009

Clinical Chemistry

Baseline Renal Function Screening

Norbert Lameire, Andy Adam · 2006

The American Journal of Cardiology

Metrics

2,927

Citations

27

References

Details

Published: Jun 01, 2005
Vol/Issue: 67(6)
Pages: 2089-2100
License: View

Authors

Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland

From Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts; Bloomberg School of Public Health, Welch Center for Prevention, Epidemiology and Clinical Research, and the Johns Hopkins University, Baltimore, Maryland; University of British Columbia, Vancouver, British Columbia, Canada; University of Minnesota, Minneapolis, Minnesota; North Texas Hospital for Children, Dallas, Texas; and Baylor College of Medicine, Houston, Texas.

Cite This Article

Andrew S. Levey, Kai-Uwe Eckardt, Yusuke Tsukamoto, et al. (2005). Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International, 67(6), 2089-2100. https://doi.org/10.1111/j.1523-1755.2005.00365.x

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

You May Also Like